BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 22494497)

  • 21. Palmitic acid-conjugated 21-nucleotide siRNA enhances gene-silencing activity.
    Kubo T; Yanagihara K; Takei Y; Mihara K; Morita Y; Seyama T
    Mol Pharm; 2011 Dec; 8(6):2193-203. PubMed ID: 21985606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amino-modified and lipid-conjugated dicer-substrate siRNA enhances RNAi efficacy.
    Kubo T; Takei Y; Mihara K; Yanagihara K; Seyama T
    Bioconjug Chem; 2012 Feb; 23(2):164-73. PubMed ID: 22236254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene-silencing potency of symmetric and asymmetric lipid-conjugated siRNAs and its correlation with dicer recognition.
    Kubo T; Yanagihara K; Sato Y; Nishimura Y; Kondo S; Seyama T
    Bioconjug Chem; 2013 Dec; 24(12):2045-57. PubMed ID: 24274056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In Vivo RNAi Efficacy of Palmitic Acid-Conjugated Dicer-Substrate siRNA in a Subcutaneous Tumor Mouse Model.
    Kubo T; Yanagihara K; Seyama T
    Chem Biol Drug Des; 2016 Jun; 87(6):811-23. PubMed ID: 26800111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant Dicer efficiently converts large dsRNAs into siRNAs suitable for gene silencing.
    Myers JW; Jones JT; Meyer T; Ferrell JE
    Nat Biotechnol; 2003 Mar; 21(3):324-8. PubMed ID: 12592410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid-conjugated 27-nucleotide double-stranded RNAs with dicer-substrate potency enhance RNAi-mediated gene silencing.
    Kubo T; Yanagihara K; Takei Y; Mihara K; Sato Y; Seyama T
    Mol Pharm; 2012 May; 9(5):1374-83. PubMed ID: 22494497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Basic research on and application of RNA interference].
    Ohta A; Inoue A; Taira K
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):827-31. PubMed ID: 15222096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small RNA: can RNA interference be exploited for therapy?
    Wall NR; Shi Y
    Lancet; 2003 Oct; 362(9393):1401-3. PubMed ID: 14585643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA interference--significance and applications.
    Stanisławska J; Olszewski WL
    Arch Immunol Ther Exp (Warsz); 2005; 53(1):39-46. PubMed ID: 15761375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional gene silencing by short interfering RNAs.
    Kawasaki H; Taira K
    Curr Opin Mol Ther; 2005 Apr; 7(2):125-31. PubMed ID: 15844619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNA interference-based gene silencing in mice: the development of a novel therapeutical strategy.
    Spänkuch B; Strebhardt K
    Curr Pharm Des; 2005; 11(26):3405-19. PubMed ID: 16250844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted gene silencing by small interfering RNA-based knock-down technology.
    Zhang J; Hua ZC
    Curr Pharm Biotechnol; 2004 Feb; 5(1):1-7. PubMed ID: 14965205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene silencing mediated by small interfering RNAs in mammalian cells.
    Scherr M; Morgan MA; Eder M
    Curr Med Chem; 2003 Feb; 10(3):245-56. PubMed ID: 12570711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineering host-derived resistance against plant parasites through RNA interference: challenges and opportunities.
    Runo S
    Bioeng Bugs; 2011; 2(4):208-13. PubMed ID: 21829096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Nanostructured RNA for RNA interference].
    Abe H
    Yakugaku Zasshi; 2013; 133(3):373-8. PubMed ID: 23449417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of Exogenous dsRNAs-induced RNAi in Agriculture: Challenges and Triumphs.
    Das PR; Sherif SM
    Front Plant Sci; 2020; 11():946. PubMed ID: 32670336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNAi--a tool for target finding in new drug development.
    Gomase VS; Tagore S
    Curr Drug Metab; 2008 Mar; 9(3):241-4. PubMed ID: 18336228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced gene delivery and/or efficacy by functional peptide and protein.
    Okuda T; Kawaguchi Y; Okamoto H
    Curr Top Med Chem; 2009; 9(12):1098-108. PubMed ID: 19860710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RNA interference: past, present and future.
    Campbell TN; Choy FY
    Curr Issues Mol Biol; 2005 Jan; 7(1):1-6. PubMed ID: 15580776
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.